Ropes & Gray advised iTeos Therapeutics in the deal. iTeos Therapeutics closed a collaboration with global healthcare leader GSK to co-develop and co-commercialize an anti-TIGIT monoclonal...
This content is for Standard 1 Year members only. LoginJoin Now